1D | 3.9 % |
1W | 1.6 % |
2W | -3.4 % |
1M | -5.7 % |
3M | -7.3 % |
6M | -7.0 % |
9M | 0.2 % |
1Y | 3.3 % |
Alpha
-18.8%
|
Beta
0.87
|
sharpe-R
0.21
|
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
|
sharpe-R Benchmark
2.12
|
Calculation Frequency | Daily |
Latest Valuation Time | 2024-09-16 06:55:24 |
Launch Date | 2023-01-01 00:00:00 |
First Valuation Date | 2021-01-01 00:00:00 |
Max. DrawDown | -17.64% |
Max. DrawDown Benchmark | -8.41% |
This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. The maximum number of assets that can be allocated in this strategy is 20.
The assets selection in this portfolio is based on: Macro-Pattern Mix St..Try Our Peformance Checker Tool
Asset | Asset Class | Action | Weight | Entry Price | Current Price | PnL | Entry Date |
---|---|---|---|---|---|---|---|
WES Western Midstream Partners, LP | Equity | Buy | 4.91% | 2.57% | 2024-09-02 | ||
MBUU Malibu Boats, Inc. | Equity | Buy | 5.06% | 5.75% | 2024-09-02 | ||
TVTX Travere Therapeutics, Inc. | Equity | Buy | 6.67% | 40.42% | 2024-09-04 | ||
ESPR Esperion Therapeutics, Inc. | Equity | Buy | 4.95% | 4.37% | 2024-09-04 | ||
SPWH Sportsman's Warehouse Holdings, Inc. | Equity | Buy | 6.22% | 22.59% | 2024-09-06 | ||
NVCR NovoCure Limited | Equity | Buy | 5.22% | 2.88% | 2024-09-06 | ||
LUMN Lumen Technologies, Inc. | Equity | Buy | 5.62% | 10.73% | 2024-09-06 | ||
MYGN Myriad Genetics, Inc. | Equity | Buy | 4.82% | 2.3% | 2024-09-09 | ||
MPW Medical Properties Trust, Inc. | Equity | Buy | 4.54% | 0% | 2024-09-16 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
WES Western Midstream Partners, LP | Buy | 4.91% | 2.57% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 5.06% | 5.75% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 6.67% | 40.42% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.95% | 4.37% | 2024-09-04 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 6.22% | 22.59% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 5.22% | 2.88% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.62% | 10.73% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.82% | 2.3% | 2024-09-09 |
MPW Medical Properties Trust, Inc. | Buy | 4.54% | 0% | 2024-09-16 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
WES Western Midstream Partners, LP | Buy | 4.94% | 0.73% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 5% | 1.9% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 6.38% | 31.25% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.65% | -4.37% | 2024-09-04 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 5.76% | 10.88% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 4.99% | -3.99% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.66% | 8.91% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.73% | -2.15% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
AGEN | Sell All | 8.41% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AGEN Agenus Inc. | Buy | 5.61% | 3.11% | 2024-08-23 |
WES Western Midstream Partners, LP | Buy | 4.94% | -0.73% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 5.03% | 1.24% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 6.29% | 27.5% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.69% | -4.92% | 2024-09-04 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 5.6% | 6.28% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 5.03% | -4.54% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.21% | -1.09% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.77% | -2.56% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
APLS | Sell All | -3.75% |
ATUS | Sell All | 6.59% |
GME | Sell All | -10.8% |
JBSS | Sell All | -4.24% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.33% | -1.69% | 2024-08-22 |
ATUS Altice USA, Inc. | Buy | 5.84% | 7.69% | 2024-08-22 |
AGEN Agenus Inc. | Buy | 5.41% | -0.18% | 2024-08-23 |
WES Western Midstream Partners, LP | Buy | 4.88% | -1.53% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 4.82% | -2.72% | 2024-09-02 |
GME GameStop Corp. | Buy | 4.98% | 1.34% | 2024-09-04 |
JBSS John B. Sanfilippo & Son, Inc. | Buy | 4.81% | -2.12% | 2024-09-04 |
TVTX Travere Therapeutics, Inc. | Buy | 6.57% | 33.75% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.65% | -5.46% | 2024-09-04 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 5.23% | -0.42% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 4.92% | -6.37% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.12% | -2.55% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.89% | 0.26% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
CARA | Sell All | -18.08% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.37% | 0.21% | 2024-08-22 |
ATUS Altice USA, Inc. | Buy | 6.04% | 12.64% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 4.85% | -9.62% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.03% | -6.22% | 2024-08-23 |
WES Western Midstream Partners, LP | Buy | 4.78% | -2.44% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 4.8% | -2.03% | 2024-09-02 |
GME GameStop Corp. | Buy | 5.1% | 4.8% | 2024-09-04 |
JBSS John B. Sanfilippo & Son, Inc. | Buy | 4.83% | -0.6% | 2024-09-04 |
TVTX Travere Therapeutics, Inc. | Buy | 6.51% | 33.96% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.52% | -7.1% | 2024-09-04 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 5.33% | 2.51% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 4.78% | -7.98% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.37% | 3.27% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.86% | 0.63% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
WOW | Sell All | -3.98% |
LPTV | Sell All | -47.73% |
UAA | Sell All | -9.36% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
WOW WideOpenWest, Inc. | Buy | 5.09% | -4.84% | 2024-08-20 |
LPTV Loop Media, Inc. | Buy | 3.16% | -40.91% | 2024-08-21 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.51% | 3% | 2024-08-22 |
ATUS Altice USA, Inc. | Buy | 6.47% | 20.88% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.03% | -6.12% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 4.85% | -9.51% | 2024-08-23 |
WES Western Midstream Partners, LP | Buy | 4.79% | -2.13% | 2024-09-02 |
MBUU Malibu Boats, Inc. | Buy | 4.87% | -0.47% | 2024-09-02 |
GME GameStop Corp. | Buy | 5.02% | 3.37% | 2024-09-04 |
JBSS John B. Sanfilippo & Son, Inc. | Buy | 4.89% | 0.66% | 2024-09-04 |
TVTX Travere Therapeutics, Inc. | Buy | 5.55% | 14.37% | 2024-09-04 |
ESPR Esperion Therapeutics, Inc. | Buy | 4.38% | -9.84% | 2024-09-04 |
UAA Under Armour, Inc. | Buy | 3.51% | -5.35% | 2024-09-05 |
SPWH Sportsman's Warehouse Holdings, Inc. | Buy | 5.19% | 0% | 2024-09-06 |
NVCR NovoCure Limited | Buy | 4.85% | -6.48% | 2024-09-06 |
LUMN Lumen Technologies, Inc. | Buy | 5.51% | 6.18% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 4.82% | 0% | 2024-09-09 |
Asset | Action | Perf % |
---|---|---|
RUN | Sell All | -10.32% |
ABG | Sell All | -5.59% |
ORGO | Sell All | -12.72% |
TSLA | Sell All | -8.45% |